Xeris Biopharma Holdings Inc (XERS)
Cost of Revenue
$55.87M
TTM · Period ending: · USD
XERS Cost of Revenue
Latest reported$55.87Mperiod ending
Latest reported$55.87Mperiod ending
XERS TTM Cost of Revenue ($4.00K → $55.87M)
TTM cost of revenue
High-resolution chart · PNG
XERS cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 55,871,000 | |
| 57,968,000 | |
| 53,412,000 | |
| 43,811,000 | |
| 46,408,000 | |
| 42,299,000 | |
| 39,542,000 | |
| 40,345,000 | |
| 34,953,000 | |
| 32,008,000 | |
| 31,356,000 | |
| 27,366,000 | |
| 24,425,000 | |
| 21,680,000 | |
| 22,634,000 | |
| 21,232,000 | |
| 19,192,000 | |
| 17,765,000 | |
| 13,318,000 | |
| 11,836,000 | |
| 11,448,000 | |
| 9,364,000 | |
| 9,328,000 | |
| 7,524,000 | |
| 4,702,000 | |
| 3,426,000 | |
| 1,636,000 | |
| 75,000 | |
| 65,000 | |
| 42,000 | |
| 84,000 | |
| 42,000 | |
| 42,000 | |
| 46,000 | |
| 4,000 |